Abbott Laboratories
ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irā¦ read more
Healthcare
Medical Devices
45 years
USD
Become a Premium user to unlock the Score details
Price
per share adjusted in USD$138.08
Price+3.62%
$4.82
5Y
Price
Market Cap
$240.237b
Large
Price/Earnings
17.9x
30.9x
3y Avg30.9x
5y AvgDividends
Ex-Dividend: July 15, 251.71%
Yield$2.36
Dividend+7.76%
Forward Dividend Growth
+7.8%
+7.9%
3y CAGR+7.2%
5y CAGRPayout
30.6%
30.6%
Payout 3y39.4%
Payout 5yYield
BenchmarkDividends
No items found.
Financials Overview
+25.7%
EBITDA Margin+12.8%
Net Profit Margin+9.0%
Free Cash Flow MarginRevenue
$42.344b
+0.9%
1y CAGR-0.9%
3y CAGR-0.3%
5y CAGREarnings
$13.502b
+0.8%
1y CAGR+39.2%
3y CAGR+28.9%
5y CAGREPS
$7.71
+0.9%
1y CAGR+39.4%
3y CAGR+29.4%
5y CAGRBook Value
$49.064b
$81.448b
Assets$32.384b
Liabilities$13.242b
DebtDebt to Assets
16.3%
1.2x
Debt to EBITDAFree Cash Flow
$6.657b
+4.8%
1y CAGR-1.6%
3y CAGR-3.6%
5y CAGRFinancial Reports
Earnings and other important metricsNo items found.
Press Releases